98 related articles for article (PubMed ID: 30022055)
1. Serum vascular adhesion protein-1 is up-regulated in hyperglycemia and is associated with incident diabetes negatively.
Kuo CH; Wei JN; Yang CY; Ou HY; Wu HT; Fan KC; Wang SH; Hua CH; Hsiao CH; Lee MK; Li HY
Int J Obes (Lond); 2019 Mar; 43(3):512-522. PubMed ID: 30022055
[TBL] [Abstract][Full Text] [Related]
2. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia.
Li HY; Wei JN; Lin MS; Smith DJ; Vainio J; Lin CH; Chiang FT; Shih SR; Huang CH; Wu MY; Hsein YC; Chuang LM
Clin Chim Acta; 2009 Jun; 404(2):149-53. PubMed ID: 19336232
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
[TBL] [Abstract][Full Text] [Related]
5. Age-, sex- and glucose-dependent correlation of plasma soluble vascular adhesion protein-1 concentration with cardiovascular risk factors and subclinical atherosclerosis.
Chen DW; Jin Y; Zhao RM; Long LJ; Zhang J; Han CL; Roivainen A; Knuuti J; Jalkanen S; Wang JC
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1544-58. PubMed ID: 27160127
[TBL] [Abstract][Full Text] [Related]
6. Serum Angiopoietin-like Protein 6, Risk of Type 2 Diabetes, and Response to Hyperglycemia: A Prospective Cohort Study.
Fan KC; Wu HT; Wei JN; Chuang LM; Hsu CY; Yen IW; Lin CH; Lin MS; Shih SR; Wang SH; Chang TJ; Li HY
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32123920
[TBL] [Abstract][Full Text] [Related]
7. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
Bournazou E; Samuels J; Zhou H; Krasnokutsky S; Patel J; Han T; Bencardino J; Rybak L; Abramson SB; Junker U; Brown KS; Attur M
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146362
[TBL] [Abstract][Full Text] [Related]
8. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
Gurecká R; Koborová I; Csongová M; Šebek J; Šebeková K
Glycoconj J; 2016 Aug; 33(4):599-606. PubMed ID: 27300745
[TBL] [Abstract][Full Text] [Related]
9. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
10. Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.
Li HY; Lin HA; Nien FJ; Wu VC; Jiang YD; Chang TJ; Kao HL; Lin MS; Wei JN; Lin CH; Shih SR; Hung CS; Chuang LM
PLoS One; 2016; 11(2):e0147981. PubMed ID: 26845338
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
[TBL] [Abstract][Full Text] [Related]
12. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects.
Li HY; Lin MS; Wei JN; Hung CS; Chiang FT; Lin CH; Hsu HC; Su CY; Wu MY; Smith DJ; Vainio J; Chen MF; Chuang LM
Clin Chim Acta; 2009 May; 403(1-2):97-101. PubMed ID: 19361461
[TBL] [Abstract][Full Text] [Related]
13. Plasma soluble vascular adhesion protein-1 concentration correlates with arterial stiffness: A cross-sectional study.
Chen DW; Zhao RM; Jin Y; Zhang J; Han C; Jiang SQ; Zheng HF; Wang JC
Arch Gerontol Geriatr; 2015; 61(1):67-71. PubMed ID: 25959807
[TBL] [Abstract][Full Text] [Related]
14. Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations.
Aalto K; Maksimow M; Juonala M; Viikari J; Jula A; Kähönen M; Jalkanen S; Raitakari OT; Salmi M
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):523-32. PubMed ID: 22116093
[TBL] [Abstract][Full Text] [Related]
15. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes.
Li HY; Jiang YD; Chang TJ; Wei JN; Lin MS; Lin CH; Chiang FT; Shih SR; Hung CS; Hua CH; Smith DJ; Vanio J; Chuang LM
Diabetes; 2011 Mar; 60(3):993-9. PubMed ID: 21282368
[TBL] [Abstract][Full Text] [Related]
16. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
17. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes.
Colak A; Akinci B; Diniz G; Turkon H; Ergonen F; Yalcin H; Coker I
Scand J Clin Lab Invest; 2013 Aug; 73(5):422-7. PubMed ID: 23767858
[TBL] [Abstract][Full Text] [Related]
18. Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study.
Aalto K; Havulinna AS; Jalkanen S; Salomaa V; Salmi M
Circ Cardiovasc Genet; 2014 Aug; 7(4):529-35. PubMed ID: 24850810
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
[TBL] [Abstract][Full Text] [Related]
20. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
